Gentian Diagnostics ASA

Share Issue/Capital Change • Feb 2, 2017

GENTIAN DIAGNOSTICS - REGISTRATION OF SHARE CAPITAL INCREASE IN THE NORWEGIAN REGISTER OF BUSINESS ENTERPRISES

GENTIAN DIAGNOSTICS - REGISTRATION OF SHARE CAPITAL INCREASE IN THE NORWEGIAN REGISTER OF BUSINESS ENTERPRISES

Oslo, 2 February 2017

Reference is made to the stock exchange announcement

following the extraordinary general meeting in Gentian

Diagnostics AS (the "Company) held on 30 January 2017

(the "EGM"). The extraordinary general meeting

approved a private placement (the "Private Placement")

comprising 2,857,143 new shares, each with par value

of NOK 0.10.

The share capital increase pertaining to the Private

Placement has been registered in the Norwegian

Register of Business Enterprises today. Following the

registration, the Company's share capital is NOK

1,399,629.30 divided into 13,996,293 shares, each with

a par value of NOK 0.10. The new shares have been

issued on the Company's ordinary ISIN and are tradable

on Merkur Market.

For more information, please contact:

Julie Alling Gryga

CFO, Gentian Diagnostics

E-mail: Julie.alling@gentian.no

Cell Phone: +47 472 62 628